S&P 500   3,378.36 (+1.34%)
DOW   27,917.28 (+0.83%)
QQQ   271.50 (+2.38%)
AAPL   449.76 (+2.80%)
MSFT   208.91 (+2.72%)
FB   260.71 (+1.79%)
GOOGL   1,505.20 (+1.67%)
AMZN   3,155.67 (+2.43%)
NVDA   454.73 (+4.78%)
CGC   17.40 (+2.65%)
BABA   255.51 (+2.85%)
TSLA   1,527.24 (+11.12%)
GE   6.61 (-1.78%)
MU   48.33 (+1.19%)
AMD   82.24 (+6.97%)
T   30.12 (-0.26%)
F   7.06 (-2.35%)
ACB   9.92 (-1.00%)
GILD   68.86 (+1.12%)
NFLX   479.79 (+2.75%)
DIS   130.63 (+0.11%)
BAC   26.47 (-1.67%)
BA   174.25 (-3.26%)
S&P 500   3,378.36 (+1.34%)
DOW   27,917.28 (+0.83%)
QQQ   271.50 (+2.38%)
AAPL   449.76 (+2.80%)
MSFT   208.91 (+2.72%)
FB   260.71 (+1.79%)
GOOGL   1,505.20 (+1.67%)
AMZN   3,155.67 (+2.43%)
NVDA   454.73 (+4.78%)
CGC   17.40 (+2.65%)
BABA   255.51 (+2.85%)
TSLA   1,527.24 (+11.12%)
GE   6.61 (-1.78%)
MU   48.33 (+1.19%)
AMD   82.24 (+6.97%)
T   30.12 (-0.26%)
F   7.06 (-2.35%)
ACB   9.92 (-1.00%)
GILD   68.86 (+1.12%)
NFLX   479.79 (+2.75%)
DIS   130.63 (+0.11%)
BAC   26.47 (-1.67%)
BA   174.25 (-3.26%)
S&P 500   3,378.36 (+1.34%)
DOW   27,917.28 (+0.83%)
QQQ   271.50 (+2.38%)
AAPL   449.76 (+2.80%)
MSFT   208.91 (+2.72%)
FB   260.71 (+1.79%)
GOOGL   1,505.20 (+1.67%)
AMZN   3,155.67 (+2.43%)
NVDA   454.73 (+4.78%)
CGC   17.40 (+2.65%)
BABA   255.51 (+2.85%)
TSLA   1,527.24 (+11.12%)
GE   6.61 (-1.78%)
MU   48.33 (+1.19%)
AMD   82.24 (+6.97%)
T   30.12 (-0.26%)
F   7.06 (-2.35%)
ACB   9.92 (-1.00%)
GILD   68.86 (+1.12%)
NFLX   479.79 (+2.75%)
DIS   130.63 (+0.11%)
BAC   26.47 (-1.67%)
BA   174.25 (-3.26%)
S&P 500   3,378.36 (+1.34%)
DOW   27,917.28 (+0.83%)
QQQ   271.50 (+2.38%)
AAPL   449.76 (+2.80%)
MSFT   208.91 (+2.72%)
FB   260.71 (+1.79%)
GOOGL   1,505.20 (+1.67%)
AMZN   3,155.67 (+2.43%)
NVDA   454.73 (+4.78%)
CGC   17.40 (+2.65%)
BABA   255.51 (+2.85%)
TSLA   1,527.24 (+11.12%)
GE   6.61 (-1.78%)
MU   48.33 (+1.19%)
AMD   82.24 (+6.97%)
T   30.12 (-0.26%)
F   7.06 (-2.35%)
ACB   9.92 (-1.00%)
GILD   68.86 (+1.12%)
NFLX   479.79 (+2.75%)
DIS   130.63 (+0.11%)
BAC   26.47 (-1.67%)
BA   174.25 (-3.26%)
Log in

OTCMKTS:GBLXGB Sciences Stock Price, Forecast & News

$0.03
0.00 (-3.75 %)
(As of 08/12/2020 01:42 PM ET)
Add
Compare
Today's Range
$0.03
Now: $0.03
$0.03
50-Day Range
$0.03
MA: $0.03
$0.03
52-Week Range
$0.02
Now: $0.03
$0.14
Volume323,937 shs
Average Volume365,775 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
GB Sciences, Inc. focuses to be a technology and solution company that converts the cannabis plant into medicines, therapies, and treatments for various ailments. The company is developing technologies in plant biology, cultivation and extraction techniques, which are combined with biotechnology; and plans to produce medical-grade cannabis, cannabis concentrates, and cannabinoid therapies. GB Sciences, Inc. has an agreement with Growblox Sciences, Puerto Rico, LLC that grants the right to its technology and intellectual property. The company was formerly known as Growblox Sciences, Inc. and changed its name to GB Sciences, Inc. in October 2016. GB Sciences, Inc. was incorporated in 2001 and is based in Las Vegas, Nevada.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.5Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.50 out of 5 stars


Industry, Sector and Symbol

Industry Biotechnology
Sub-IndustryCannabis
SectorMedical
Current SymbolOTCMKTS:GBLX
CUSIPN/A
Phone+1-888-8953594

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

Employees60
Next Earnings Date8/13/2020 (Estimated)
OptionableNot Optionable
$0.03
0.00 (-3.75 %)
(As of 08/12/2020 01:42 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive GBLX News and Ratings via Email

Sign-up to receive the latest news and ratings for GBLX and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











GB Sciences (OTCMKTS:GBLX) Frequently Asked Questions

How has GB Sciences' stock been impacted by COVID-19 (Coronavirus)?

GB Sciences' stock was trading at $0.03 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, GBLX stock has increased by 2.7% and is now trading at $0.0308.
View which stocks have been most impacted by Coronavirus
.

When is GB Sciences' next earnings date?

GB Sciences is scheduled to release its next quarterly earnings announcement on Thursday, August 13th 2020.
View our earnings forecast for GB Sciences
.

How were GB Sciences' earnings last quarter?

GB Sciences Inc (OTCMKTS:GBLX) released its earnings results on Monday, November, 14th. The company reported ($0.04) earnings per share for the quarter.
View GB Sciences' earnings history
.

Has GB Sciences been receiving favorable news coverage?

Media coverage about GBLX stock has trended negative recently, InfoTrie Sentiment Analysis reports. InfoTrie identifies positive and negative news coverage by monitoring more than six thousand news and blog sources. The firm ranks coverage of companies on a scale of negative five to five, with scores closest to five being the most favorable. GB Sciences earned a media sentiment score of -2.2 on InfoTrie's scale. They also assigned news coverage about the company a news buzz of 10.0 out of 10, indicating that recent news coverage is extremely likely to have an effect on the stock's share price in the immediate future.
View the latest news about GB Sciences
.

Are investors shorting GB Sciences?

GB Sciences saw a increase in short interest in March. As of March 13th, there was short interest totaling 21,700 shares, an increase of 4,240.0% from the February 27th total of 500 shares. Based on an average daily volume of 913,200 shares, the days-to-cover ratio is currently 0.0 days.
View GB Sciences' Short Interest
.

Who are some of GB Sciences' key competitors?

What other stocks do shareholders of GB Sciences own?

Based on aggregate information from My MarketBeat watchlists, some companies that other GB Sciences investors own include Chesapeake Energy (CHKAQ), Chesapeake Energy (CHKAQ), KushCo (KSHB), Medical Marijuana (MJNA), Cannabics Pharmaceuticals (CNBX), MassRoots (MSRT), Surna (SRNA), Gran Tierra Energy (GTE), Marimed (MRMD) and Pennsylvania R.E.I.T. (PEI).

Who are GB Sciences' key executives?

GB Sciences' management team includes the following people:
  • Mr. John C. Poss, Chairman & CEO (Age 71)
  • Ms. Ksenia Griswold, COO, CFO, VP & Controller (Age 36)
  • Dr. Andrea Small-Howard M.B.A., Ph.D., MBA, Chief Science Officer & Director (Age 50)
  • Mr. Krin Ellery Kuethe, Sr. VP of Cultivation (Age 35)
  • Mr. John B. Davis, Gen. Counsel & Exec. VP

What is GB Sciences' stock symbol?

GB Sciences trades on the OTCMKTS under the ticker symbol "GBLX."

How do I buy shares of GB Sciences?

Shares of GBLX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is GB Sciences' stock price today?

One share of GBLX stock can currently be purchased for approximately $0.03.

What is GB Sciences' official website?

The official website for GB Sciences is gbsciences.com.

How can I contact GB Sciences?

GB Sciences' mailing address is 6450 Cameron St Ste 110A, LAS VEGAS, NV 89118-4337, United States. The company can be reached via phone at +1-888-8953594.

This page was last updated on 8/12/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.